4DMedical Limited (ASX:4DX)
4.000
-0.170 (-4.08%)
May 18, 2026, 4:10 PM AEST
4DMedical Company Description
4DMedical Limited operates as a medical technology company in Australia and the United States.
It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator.
The company was incorporated in 2012 and is based in Carlton, Australia.
4DMedical Limited

| Country | Australia |
| Founded | 2012 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 124 |
| CEO | Andreas Fouras |
Contact Details
Address: Melbourne Connect Carlton, VIC VIC Australia | |
| Phone | 61 3 9545 5940 |
Stock Details
| Ticker Symbol | 4DX |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000095416 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Dr. Andreas Fouras M.A.I.C.D., Ph.D. | Founder, MD, Chief Executive Officer and Director |
| Julian Sutton B.Sc., C.F.A. | Chief Financial Officer and Executive Director |
| Matt Tucker | Chief Commercial Officer |
| Beth Plunkett | Senior Legal Counsel |
| Dr. Aidan Jamison B.E., Ph.D. | Senior Vice President of Engineering |
| Rachael Tenkaten | Senior Vice President of Product |
| Dr. Greg T. Mogel M.D. | Chief Medical Officer |
| David Hannes B.S., M.B.A. | Senior Vice President of Global Business Development |
| Hamish George B.Com., C.A. | Company Secretary |